Surgery, Gastroenterology and Oncology
Vol. 20, No. 3, September 2015
Circulating miR-21 and TGF-b1 expression levels in patients with cardiovascular diseases
Irina Huica, Iulia V. Iancu, Anca Botezatu, Otilia Banu, Elena Lupeanu, Mariana Anton
ORIGINAL PAPER, September 2015
Article DOI: 10.21614/jtmr-20-3-44
Recent works focus on the role microRNAs (miRNAs) play in regulation of cardiovascular pathology. One of the miRNAs highly expressed in cardiovascular system is miR-21. The aim of this study was to investigate the relationship between the expression level of miR-21 in cardiac disease and correlate with TGF-b1, one of its targets.

Methods: Plasma samples from patients with CVD (cardiovascular diseases) established according to clinical and paraclinical exams were subjected to total RNAs isolation. miR-21 expression levels in patients with CVD and in healthy control subjects were quantified on ABI 7300 real-time PCR (Applied BioSystems) and normalized to RNU-43. TGF-b1 was predicted as potential target of miR-21 using MicroCosm TARGETS and quantified in TaqMan system (normalized to GAPDH). Statistical analysis was performed with GraphPad Prism.

Results: Significant lower levels of miR-21 were found in CVD patients vs. controls (p<0.0001). An inverse correlation between miR-21 and TGF-β1 expression levels was noted in CVD patients. miR-21 levels vs. control were significantly different for ATHE, CAD and ATH groups (p=0.0016, 0.0058 and 0.0032 respectively) and correlated with TGF-b1 expression and cardiac overload.

Conclusions: The results of this study suggest a good correlation between miR-21 and TGF-b1 in cardiovascular diseases.

Keywords: miR-21, TGF-b1, cardiovascular disease.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2981


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.